Nephrocare Subsidiary Completes Asset Acquisition of Dialysis Center in Philippines
Nephrocare Health Care Services, Philippines Inc., an overseas step-down wholly-owned subsidiary of Nephrocare Health Services Limited, has executed an Asset Transfer Agreement regarding the acquisition of a dialysis center. The transaction involves purchasing identified assets from Inocentes Dialysis Clinic.The agreement, dated June 04, 2026, covers the acquisition of assets related to a dialysis facility located in Duyan-Duyan, Project 3, Quezon City, Philippines. The total consideration for these identified assets amounts to PHP 30,000,000 (Thirty Million Pesos only).
The purchase was conducted by Nephrocare Health Care Services, Philippines Inc., which serves as the Purchaser in the agreement with Inocentes Dialysis Clinic acting as the Seller. The transaction is part of a strategy involving the acquisition of operating assets related to the specialized healthcare facility.
Key details of the asset transfer agreement are summarized below:
| Particulars | Detail |
|---|---|
| Purchaser | Nephrocare Health Care Services, Philippines Inc. (Overseas wholly-owned subsidiary) |
| Seller | Inocentes Dialysis Clinic |
| Transaction Date | June 04, 2026 |
| Assets Acquired | Identified assets of a dialysis center in Quezon City, Philippines |
| Total Consideration | PHP 30,000,000 (Thirty Million Pesos only) |
| Special Rights in Agreement | No special rights are stipulated as per the agreements. |
The terms indicate that there are no shared interests or relationships between the parties that would classify the transaction as a related party deal, with both the Purchaser and Seller operating on an arm's length basis.
NEPHROPLUS Stock Price Movement
Shares of Nephrocare Health Services Limited today slipped by 0.04%, finishing post-market at ₹661, driven by minor selling pressure. The muted close saw the stock touch remarkable heights near its 52-week maximum, with a volume totaling 100,019 shares recorded during trading hours.Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.
Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.